Granules India informs about audited financial results

15 May 2024 Evaluate
Granules India has informed that the Board of Directors at their meeting has approved the audited financial results (Standalone & Consolidated) for the fourth quarter and financial year ended on March 31, 2024 prepared under Indian Accounting Standards (Ind - AS) along with the Auditor’s report thereon. Pursuant to regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), they are enclosing the audited financial results (Standalone and Consolidated) of the Company for the fourth quarter and financial year ended on March 31, 2024. They hereby confirmed and declared that the statutory auditors of the Company, S R Batliboi & Associates LLP, Chartered Accountants registered vide Firm Registration No. 101049W/E300004 have in their report issued an unmodified opinion on the standalone and consolidated financial results for the financial year ended on March 31, 2024. They also enclosed a copy of the report of the Company’s statutory auditors, as required under Regulation 33 of the Listing Regulations. The meeting of the Board of Directors of the Company commenced at 09.00 AM and concluded at 12.10 PM.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

558.90 13.45 (2.47%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.